indican has been researched along with Chronic Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Liu, L; Liu, XY; Liu, YF; Lu, C; Tang, MY; Wu, L; Zhang, C | 1 |
| Amaki, M; Fukuda, H; Hasegawa, T; Hitsumoto, T; Imazu, M; Ito, S; Kanzaki, H; Kitakaze, M; Morita, T; Takahama, H; Tsukamoto, O | 1 |
| Aoyagi, M; Inaba, N; Kanda, E; Maeda, Y; Shiigai, T; Tanase, T; Tomura, S | 1 |
| Aparicio, M; Chauveau, P; Fouque, D | 1 |
| Barreto, DV; Barreto, FC; Choukroun, G; Glorieux, G; Liabeuf, S; Massy, ZA; Meert, N; Temmar, M; Vanholder, R | 1 |
| Fujinaga, S; Hara, S; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Fujita, T; Inagi, R; Kawakami, T; Nangaku, M; Tanaka, T; Wada, T | 1 |
| Kojima, T; Morimoto, A; Morita, T; Namba, S; Okuda, Y | 1 |
| Kang, DH; Kim, YJ; Yu, M | 1 |
| Meyer, TW; Sirich, T | 1 |
| Evenepoel, P; Meijers, BK | 1 |
| Fujii, H; Fukagawa, M; Nakai, K | 1 |
| Maruyama, T; Miyamoto, Y; Otagiri, M; Watanabe, H | 1 |
| Niwa, T | 1 |
| Argiles, A; Cohen, G; De Smet, R; Duranton, F; Jankowski, J; Rodriguez, M; Vanholder, R | 1 |
| Niwa, T; Taki, K | 1 |
| Ishida, T; Kawakami, Y; Ogura, S | 1 |
| Aarbakke, J; Schjönsby, H | 1 |
| Glukhen'kiĭ, TT | 1 |
| Booth, CC; Mollin, DL; Tabaqchali, S | 1 |
2 review(s) available for indican and Chronic Disease
| Article | Year |
|---|---|
Indoxyl sulfate in atherosclerosis.
Topics: Albumins; Atherosclerosis; Cardiovascular Diseases; Chronic Disease; Humans; Indican; Renal Insufficiency, Chronic; Uremia | 2023 |
Normal and pathologic concentrations of uremic toxins.
Topics: beta 2-Microglobulin; Chronic Disease; Homocysteine; Humans; Indican; Kidney Diseases; Parathyroid Hormone; Toxins, Biological; Uremia; Uric Acid | 2012 |
1 trial(s) available for indican and Chronic Disease
| Article | Year |
|---|---|
[Examination of activated charcoal preparations in chronic kidney disease: comparing Kremezin (K) and Merckmezin (M)].
Topics: Adult; Aged; Biomarkers; Carbon; Chronic Disease; Creatinine; Drugs, Generic; Female; Humans; Indican; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Oxides; Prospective Studies | 2009 |
17 other study(ies) available for indican and Chronic Disease
| Article | Year |
|---|---|
Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure.
Topics: Adult; Aged; Biomarkers; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiovascular Physiological Phenomena; Chronic Disease; Female; Heart Failure; Humans; Indican; Kaplan-Meier Estimate; Male; Middle Aged; Plasma; Prognosis; Ventricular Dysfunction, Left | 2020 |
Effect of a very low-protein diet on long-term outcomes.
Topics: Chronic Disease; Diet, Protein-Restricted; Humans; Indican; Kidney Diseases; Prognosis; Treatment Outcome; Tryptophan | 2009 |
Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.
Topics: Adult; Aged; Chronic Disease; Female; Glomerular Filtration Rate; Humans; Indican; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Proportional Hazards Models; Vascular Diseases | 2009 |
Serum indoxyl sulfate as an early marker for detecting chronic cyclosporine nephrotoxicity.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Chronic Disease; Cyclosporine; Early Diagnosis; Female; Humans; Immunosuppressive Agents; Indican; Kidney Diseases; Male; Young Adult | 2010 |
Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress.
Topics: Animals; Carbon; Cell Death; Cell Line; Cell Proliferation; Chronic Disease; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Endoplasmic Reticulum; Extracellular Signal-Regulated MAP Kinases; Humans; Indican; Interleukin-6; Kidney Diseases; Kidney Tubules, Proximal; Male; Nephrectomy; Oxides; Rats; Rats, Sprague-Dawley; Signal Transduction; Stress, Physiological; Transcription Factor CHOP | 2010 |
[Serum indoxyl sulfate is a useful predictor for progression of chronic kidney disease].
Topics: Aged; Biomarkers; Chronic Disease; Disease Progression; Female; Humans; Indican; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests | 2010 |
Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.
Topics: Adult; Carbon; Cells, Cultured; Chronic Disease; Endothelial Cells; Female; Humans; Indican; Kidney Diseases; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Oxides; Prospective Studies | 2011 |
Indoxyl sulfate: long suspected but not yet proven guilty.
Topics: Carbon; Chronic Disease; Endothelial Cells; Glomerular Filtration Rate; Humans; Indican; Kidney Diseases; Oxides; Vascular Diseases | 2011 |
The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression.
Topics: Chronic Disease; Cresols; Disease Progression; Humans; Indican; Kidney Diseases; Sulfuric Acid Esters | 2011 |
Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Topics: Animals; Carbon; Cardiovascular Diseases; Chronic Disease; Disease Progression; Drug Delivery Systems; Humans; Indican; Kidney Diseases; Oxidative Stress; Oxides; Uremia | 2011 |
New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Chronic Disease; Humans; Indican; Kidney Diseases; Oxidants; Oxidation-Reduction; Oxidative Stress; Uremia | 2011 |
Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Topics: Animals; Carbon; Cardiovascular Diseases; Chronic Disease; Disease Progression; Humans; Indican; Kidney Diseases; Oxidative Stress; Oxides; Protein Binding; Rats; Uremia | 2011 |
Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease.
Topics: Acrolein; Administration, Oral; Adsorption; Animals; Biomarkers; Carbon; Chronic Disease; Creatinine; Disease Progression; Gastrointestinal Agents; Indican; Kidney Diseases; Male; Oxidative Stress; Oxides; Prognosis; Rats; Rats, Sprague-Dawley | 2007 |
[Five cases of purple urine bag syndrome in a geriatric ward].
Topics: Aged; Catheters, Indwelling; Cerebral Infarction; Chronic Disease; Female; Humans; Indican; Syndrome; Urinary Catheterization; Urinary Tract Infections | 1999 |
Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome.
Topics: Aged; Blind Loop Syndrome; Celiac Disease; Chronic Disease; Cresols; Female; Gastrectomy; Humans; Indican; Male; Middle Aged; Pancreatitis; Phenols | 1976 |
[Significance of indican determination in the urine in patients with eczema].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Eczema; Female; Humans; Indican; Infant; Male; Middle Aged | 1967 |
Comparison of stagnant-loop syndrome with chronic tropical sprue.
Topics: Anemia, Macrocytic; Anti-Bacterial Agents; Bile Acids and Salts; Biopsy; Chronic Disease; Cobalt Isotopes; Fats; Feces; Folic Acid; Hemoglobinometry; Humans; Indican; Intestinal Diseases; Intestinal Secretions; Intestine, Small; Jejunum; Malabsorption Syndromes; Sprue, Tropical; Time Factors; Vitamin B 12; Xylose | 1968 |